First Imagine invests in HydRegen’s $8M Series A
First Imagine has invested in HydRegen, the Oxford University spin-out developing enzyme-based biocatalysis, as part of its $8M (£6M) Series A funding round led by Genoa Ventures. HydRegen replaces precious-metal catalysts in hydrogenation with a proprietary enzyme platform that operates inside standard manufacturing equipment, cutting operating costs by up to 40% while significantly reducing emissions. …
First Imagine invests in HydRegen’s $8M Series A Read More »